
Drug-maker Valeant begins exchange offer for Allergan
By Rod Nickel (Reuters) - Valeant Pharmaceuticals Inc said on Wednesday it began an exchange offer for Botox maker Allergan Inc, taking its hostile $50.8 billion bid directly to shareholders....

